Hikma Pharmaceuticals Dirección
Dirección controles de criterios 3/4
El CEO de Hikma Pharmaceuticals' es Riad Mishlawi , nombrado en Sep 2023, tiene una permanencia de menos de un año. compensación anual total es $1.55M, compuesta por 21.5% salario y 78.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.19% de las acciones de la empresa, por valor de £7.84M. La antigüedad media del equipo directivo y de la junta directiva es de 3.4 años y 4.8 años, respectivamente.
Información clave
Riad Mishlawi
Chief Executive Officer (CEO)
US$1.6m
Compensación total
| Porcentaje del salario del CEO | 21.5% |
| Permanencia del CEO | less than a year |
| Participación del CEO | 0.2% |
| Permanencia media de la dirección | 3.5yrs |
| Promedio de permanencia en la Junta Directiva | 4.9yrs |
Actualizaciones recientes de la dirección
Recent updates
Is Hikma Pharmaceuticals PLC (LON:HIK) Trading At A 29% Discount?
Apr 24
Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Apr 02Hikma Pharmaceuticals PLC's (LON:HIK) Share Price Matching Investor Opinion
Feb 25Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Dec 27An Intrinsic Calculation For Hikma Pharmaceuticals PLC (LON:HIK) Suggests It's 43% Undervalued
Dec 12Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Sep 19Calculating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Sep 01Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Jun 21Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 28% Above Its Share Price
Jun 02Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Mar 14Calculating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Feb 21Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Sep 27Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 24These 4 Measures Indicate That Hikma Pharmaceuticals (LON:HIK) Is Using Debt Reasonably Well
Jun 06Here's Why Hikma Pharmaceuticals (LON:HIK) Can Manage Its Debt Responsibly
Feb 26Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 92% Above Its Share Price
Dec 01Is Hikma Pharmaceuticals (LON:HIK) Using Too Much Debt?
Nov 11Is There An Opportunity With Hikma Pharmaceuticals PLC's (LON:HIK) 32% Undervaluation?
Sep 02Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Aug 09Hikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 26% Below Their Intrinsic Value Estimate
May 21Hikma Pharmaceuticals (LON:HIK) Seems To Use Debt Quite Sensibly
May 03It's Unlikely That Hikma Pharmaceuticals PLC's (LON:HIK) CEO Will See A Huge Pay Rise This Year
Apr 16How Does Hikma Pharmaceuticals PLC (LON:HIK) Stand Up To These Simple Dividend Safety Checks?
Apr 13Hikma Pharmaceuticals PLC (LON:HIK) Looks Interesting, And It's About To Pay A Dividend
Mar 14Hikma Pharmaceuticals PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 28I Ran A Stock Scan For Earnings Growth And Hikma Pharmaceuticals (LON:HIK) Passed With Ease
Feb 22Is There An Opportunity With Hikma Pharmaceuticals PLC's (LON:HIK) 23% Undervaluation?
Feb 03Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$333k | US$190m |
Compensación vs. Mercado: La compensación total de Riad($USD1.55M) está por debajo de la media de empresas de tamaño similar en el mercado UK ($USD3.31M).
Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Riad con los resultados de la empresa.
CEO
Riad Mishlawi (59 yo)
less than a year
Permanencia
US$1,552,833
Compensación
Mr. Riad Ali Mishlawi serves as Chief Executive Officer of Hikma Pharmaceuticals PLC since September 01, 2023 and serves as its Director since September 01, 2023. He had been the President of Injectables s...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 16.8yrs | US$3.57m | 0.38% $ 16.7m | |
| CEO & Director | less than a year | US$1.55m | 0.19% $ 8.4m | |
| Executive Vice Chairman & President of MENA | 18.7yrs | US$2.84m | 0.63% $ 27.3m | |
| Chief Financial Officer | 13.3yrs | sin datos | 0.20% $ 8.8m | |
| Chief Information Officer | no data | sin datos | sin datos | |
| Associate Director of Investor Relations | no data | sin datos | sin datos | |
| General Counsel | no data | sin datos | sin datos | |
| Executive Vice President of Corporate Development and M&A | 10.2yrs | sin datos | 0.28% $ 12.1m | |
| Chief People Officer | less than a year | sin datos | sin datos | |
| Executive Vice President of Strategic Planning & Global Affairs | 6.3yrs | sin datos | sin datos | |
| Executive Officer | 6.9yrs | sin datos | sin datos | |
| President of Injectables Business | less than a year | sin datos | sin datos |
3.5yrs
Permanencia media
59yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de HIK se considera experimentado (3.4 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 16.8yrs | US$3.57m | 0.38% $ 16.7m | |
| CEO & Director | less than a year | US$1.55m | 0.19% $ 8.4m | |
| Executive Vice Chairman & President of MENA | 18.7yrs | US$2.84m | 0.63% $ 27.3m | |
| Senior Independent Non-Executive Director | 1.5yrs | US$149.27k | sin datos | |
| Independent Non-Executive Director | 7.6yrs | US$176.38k | 0.0032% $ 139.2k | |
| Independent Non-Executive Director | 8.2yrs | US$159.69k | 0.0016% $ 68.7k | |
| Non-Executive Director | 18.6yrs | US$116.72k | 0.52% $ 22.8m | |
| Independent Non-Executive Director | 4yrs | US$149.85k | 0.0020% $ 88.3k | |
| Independent Non-Executive Director | 1.5yrs | US$127.05k | 0.00045% $ 19.6k | |
| Independent Non-Executive Director | 4.9yrs | US$134.68k | 0.00050% $ 21.7k | |
| Chairman of West-ward Pharmaceuticals | no data | sin datos | sin datos | |
| Independent Non-Executive Director | 1.6yrs | US$124.98k | sin datos |
4.9yrs
Permanencia media
65yo
Promedio de edad
Junta con experiencia: La junta directiva de HIK se considera experimentada (4.8 años de antigüedad promedio).